VENMYZE

Serial Number 98624199
730

Registration Progress

Application Filed
Jun 28, 2024
Under Examination
Jan 7, 2025
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Jan 07, 2026 159 days

Trademark Image

VENMYZE

Basic Information

Serial Number
98624199
Filing Date
June 28, 2024
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jul 2, 2025
Application
Pending
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
NEW BRUNSWICK, NJ

JOHNSON & JOHNSON

Owner at Publication
03
NEW BRUNSWICK, NJ

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

Next Deadline
159 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
January 07, 2026
Extension Available
Until January 07, 2026

Application History

12 events
Date Code Type Description Documents
Jul 2, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 2, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 2, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 2, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 30, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 22, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 28, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 28, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers

Classification

International Classes
005